Overall, PVs in both BRCA1/2 and in non-BRCA genes grouped together are slightly more frequent at the somatic level in pancreatic cancer, whereas in prostate cancer, somatic PVs are twice as many as germline PVs. This evidence concerns the gene BRCA1 and prostate cancer.